UNILATERAL TRANSIENT VISION LOSS FOLLOWING BILATERAL INTRAVITREAL OCRIPLASMIN – CASE REPORT WITH TWO YEARS FOLLOW UP
Abstract Background: Ocriplasmin is a serine protease approved for the treatment of symptomatic vitreomacular traction (VMT). Post-marketing experience has revealed safety concerns. Materials and Methods: Retrospective case report. Clinical and surgical data were analyzed. Results: We report a case...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | report |
| Idioma: | eng |
| Publicado em: |
2020
|
| Assuntos: | |
| Texto completo: | https://doi.org/10.48560/rspo.20166 |
| País: | Portugal |
| Oai: | oai:ojs.revistas.rcaap.pt:article/20166 |